WebJul 15, 2024 · CUTISS has its own R&D labs and is building its own GMP facility to scale up manufacturing at the Biotechnopark in Zurich-Schlieren. A Series B financing round was closed in June 2024 with 20 million CHF via existing and new investors (family offices and private individuals). WebThis Q2 2024, CUTISS is now expanding in France with the opening of CUTISS Innovation, an R&D centre based in Sophia-Antipolis, Europe’s leading technology park. The French region Provence-Alpes-Côte D'Azur backs CUTISS Innovation with a grant of EUR 300,000.

CUTISS – Personalised skin technology to treat skin …

WebThe Curtiss Hex Pack (CHP) is another first-of-its-kind innovation. Non-conductive coolant is contained in a proprietary, sealed aluminum vessel. The coolant is circulated under pressure from rear to front through the CHP, comes into direct contact with each individual cell, absorbs heat, and transfers it to the exterior of the vessel where it ... WebCUTISS AG, a biotech company spin-off of the University of Zurich (UZH), focuses on the development of personalized bioengineered skin graft products for the treatment of skin … covid test steiermark apotheke

Revolutionary skin graft UBS Global

WebHomepage Press and Downloads CUTISS. June 24, 2024. CUTISS. When patients suffer from disastrous large and deep burns, the ability to quickly, affordably and consistently provide large quantities of skin grafts is essential. Share this article. WebThis event is an extension of the Clinical Innovation Initiative started about six years ago by Greta Brunet, senior director of investments with the Emerging Company Development … WebThe Connecticut Bioscience Innovation Fund is a $200 million evergreen fund focused on bioscience investment. Learn More. covid teststation villach